Department Chair ad interim, Department of Lymphoma/Myeloma, Division of Cancer Medicine; Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine; Florence Maude Thomas Cancer Research Professorship, Department of Lymphoma/Myeloma, Division of Cancer Medicine; Professor, Experimental Therapeutics, Division of Cancer Medicine
Robert Z. Orlowski, MD, PhD, is Chairman, Ad Interim, Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Professor, Experimental Therapeutics, Division of Cancer Medicine, at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. He is board-certified in internal medicine and medical oncology. Dr. Robert Z. Orlowski earned his doctoral degree in molecular biophysics and biochemistry from Yale University and his medical degree from the Yale University School of Medicine. He completed his internship and residency in Internal Medicine at Barnes Hospital at the Washington University in St. Louis School of Medicine. Dr. Orlowski has published numerous book chapters, articles, and abstracts on cancer therapy, with a focus on the molecular pathogenesis of oncologic disease processes and the mechanisms of action of chemotherapeutics. His clinical research efforts focus on the translation of promising laboratory based findings into novel clinical trials for patients with hematologic malignancies.
years treating myeloma: 15
Number of Myeloma Patients Treated Annually: 200-500
Details & contact info
University of Texas MD Anderson Cancer Center Bates Avenue
Houston, TX, United States, 77030
Send a message to Robert Z. Orlowski, MD, PHD